Home
Applications
In Vitro In Vivo Correlation (IVIVC)

Equipment, Systems, and Benefits

In Vitro In Vivo Correlation (IVIVC)

In Vitro – In Vivo Correlation (IVIVC) is a predictive mathematical model that describes the relationship between the in vitro properties of a dosage form and the relevant in vivo response. Defined by the FDA, IVIVC aims to streamline drug development by predicting how a drug behaves in the human body based on laboratory tests. Despite limited FDA guidance, interest in IVIVC is growing, particularly for generic drug development. This approach can significantly reduce costs and risks associated with clinical trials, making it a valuable tool in pharmaceutical research.

IVIVC - Beyond Routine APSD Testing

IVIVC testing involves numerous variables that are not accounted for in routine APSD testing. Unlike the controlled environment of APSD tests, real-world factors such as complex airway geometries, varying patient breathing patterns (which are not simple square waves), and the dissolution of particles in lung fluid or membranes all impact drug delivery and absorption. Additional variables (e.g. the use of facemasks) can affect how particles behave and deposit in the lungs. These variables make IVIVC testing essential for providing a more accurate prediction of in vivo performance compared to standard APSD testing.

Key Components of IVIVC

A successful IVIVC system relies on accurate equipment and methodologies. Essential components include anatomically correct mouth and throat models, such as the Alberta Idealized Throat (AIT), and advanced breathing simulators. These tools replicate real-life conditions, providing reliable data on how drugs will perform in patients. This setup is crucial for developing effective and safe medications, particularly for respiratory conditions.

Benefits of IVIVC

The IVIVC philosophy is a crucial step towards reducing costs and risks in clinical trials. For Orally Inhaled & Nasal Drug Products (OINDP), IVIVC represents a relatively low-cost investment, often utilizing existing equipment. Additionally, IVIVC is expanding into dissolution testing for OINDPs, using methods like paddle-over-disc with special membranes to replicate lung absorption. This approach not only enhances the accuracy of drug testing but also accelerates the development process, making it a valuable asset in pharmaceutical research.

Optimizing MDI Performance with Realistic Testing

In MDIs, realistic APSD testing through in vitro–in vivo correlation (IVIVC) provides a deeper understanding of how the drug will behave in the lungs under real-world conditions. Unlike routine APSD testing, IVIVC accounts for patient-specific factors like varied breathing patterns and complex airway geometries. By simulating these variables, IVIVC testing helps optimize particle size distribution and inhalation technique, ensuring that the medication reaches the intended regions of the lungs effectively, improving therapeutic outcomes for patients.

Enhancing DPI Efficiency Through IVIVC Simulation

Dry Powder Inhalers (DPIs) require accurate particle size distribution to ensure the drug is efficiently delivered to the lungs, particularly since DPIs are breath-actuated. Realistic APSD testing through IVIVC can simulate varying patient inhalation strengths and breathing patterns, providing more reliable data on how particles will behave under actual use conditions. This approach helps to minimize particle agglomeration and ensures that the drug disperses evenly within the respiratory system, making it an invaluable tool for optimizing DPI design and performance.

Improving Nebulizer Consistency with Real-World APSD Testing

For nebulizers, realistic APSD testing with IVIVC is critical due to the prolonged nature of treatment and the complex dynamics of aerosol delivery. Factors like humidity, temperature, and particle dissolution in lung fluids can significantly impact how the drug is delivered and absorbed. IVIVC testing simulates these variables along with the use of facemasks and diverse breathing profiles, providing a more accurate representation of drug deposition and performance. This testing ensures that nebulizers deliver consistent and effective doses over time, enhancing the overall reliability of the device.

Frequently asked questions

Q. What equipment is used in IVIVC testing?

Key equipment includes anatomically correct mouth and throat models, like the Alberta Idealized Throat (AIT), and advanced breathing simulators to replicate real-life conditions.

Q. What is the Alberta Idealized Throat (AIT)?

The AIT is an industry-standard model for mouth and throat geometry, available in variations from child to adult, used to simulate drug delivery in IVIVC testing.

Q. How does IVIVC benefit drug development?

IVIVC reduces costs and risks by providing early insights into a drug’s performance. It helps in developing effective and safe medications, particularly for respiratory conditions.

Improving IVIVC for Inhalation Products

Enhancing IVIVC for inhalation drugs involves replicating patient breathing, using advanced geometries, simulating lung diffusion, and improving facemask fit, ensuring better lab-to-patient drug performance.

Equipment, Systems, and Benefits

In Vitro In Vivo Correlation (IVIVC)

"Realistic APSD Testing"

Frequently asked questions

Product Recommendations